Lynette CPA - Pennant Chief Officer
| PNTG Stock | USD 30.50 0.28 0.91% |
Executive
Lynette CPA is Chief Officer of Pennant Group
| Age | 46 |
| Address | 1675 East Riverside Drive, Eagle, ID, United States, 83616 |
| Phone | 208 506 6100 |
| Web | https://www.pennantgroup.com |
Pennant Management Efficiency
The company has return on total asset (ROA) of 0.0383 % which means that it generated a profit of $0.0383 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1367 %, meaning that it created $0.1367 on every $100 dollars invested by stockholders. Pennant's management efficiency ratios could be used to measure how well Pennant manages its routine affairs as well as how well it operates its assets and liabilities. The Pennant's current Return On Equity is estimated to increase to 0.13, while Return On Tangible Assets are projected to decrease to 0.03. At this time, Pennant's Asset Turnover is most likely to slightly decrease in the upcoming years.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Nathan Vaughn | ModivCare | N/A | |
| Michael Nelson | Universal Health Services | N/A | |
| Varun Gadhok | Surgery Partners | N/A | |
| Andrew Price | Encompass Health Corp | 57 | |
| Victor Radina | Universal Health Services | N/A | |
| Roxanne Womack | Surgery Partners | N/A | |
| Jim Clark | Universal Health Services | N/A | |
| Jason Bundick | Healthcare Services Group | 47 | |
| Marissa Brittenham | Surgery Partners | 39 | |
| Elissa Charbonneau | Encompass Health Corp | 64 | |
| Neil Zieselman | Surgery Partners | 48 | |
| Kenneth Shepard | ModivCare | 43 | |
| Matthew Klein | Universal Health Services | N/A | |
| Danielle Burkhalter | Surgery Partners | 39 | |
| Patrick Esq | Healthcare Services Group | 49 | |
| Maria Zangardi | Universal Health Services | N/A | |
| Henry Toledo | ModivCare | N/A | |
| Jessica Kral | ModivCare | N/A | |
| Chad JD | The Ensign Group | 46 | |
| Edward Sim | Universal Health Services | 52 | |
| MS DO | Encompass Health Corp | 64 | |
Management Performance
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0383 |
Pennant Group Leadership Team
Elected by the shareholders, the Pennant's board of directors comprises two types of representatives: Pennant inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pennant. The board's role is to monitor Pennant's management team and ensure that shareholders' interests are well served. Pennant's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pennant's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Derek Bunker, Exec Officer | ||
| Brian Wayment, President Healthcare | ||
| Jason Steik, Chief Officer | ||
| Kirk Cheney, General Secretary | ||
| Brent Guerisoli, Chief Officer | ||
| Jennifer CPA, Chief Officer | ||
| Lynette CPA, Chief Officer | ||
| John Gochnour, Chief Officer |
Pennant Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Pennant a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0383 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 1.43 B | ||||
| Shares Outstanding | 34.35 M | ||||
| Shares Owned By Insiders | 3.94 % | ||||
| Shares Owned By Institutions | 78.47 % | ||||
| Number Of Shares Shorted | 662.68 K | ||||
| Price To Earning | 34.12 X |
Currently Active Assets on Macroaxis
When determining whether Pennant Group is a strong investment it is important to analyze Pennant's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pennant's future performance. For an informed investment choice regarding Pennant Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pennant Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pennant. If investors know Pennant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pennant listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.365 | Earnings Share 0.68 | Revenue Per Share 21.663 | Quarterly Revenue Growth 0.289 | Return On Assets 0.0383 |
The market value of Pennant Group is measured differently than its book value, which is the value of Pennant that is recorded on the company's balance sheet. Investors also form their own opinion of Pennant's value that differs from its market value or its book value, called intrinsic value, which is Pennant's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pennant's market value can be influenced by many factors that don't directly affect Pennant's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pennant's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pennant is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pennant's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.